Samsung Epis Holdings Co., Ltd. (KOSE: A0126Z0)
Health Care · Biotechnology · KR
₩342,500.00
-0.44% today · -21.9% 1Y
Public summary
A free snapshot of Samsung Epis Holdings Co., Ltd., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app Samsung Epis Holdings Co., Ltd. (KOSE: A0126Z0) operates in the Biotechnology industry within the Health Care sector. The company is valued at $6.36B.
Over the last twelve months the share price has lost 21.9%, trading between 297.50K and 773.00K.
Tweenvest scores Samsung Epis Holdings Co., Ltd. across four factors: quality 66/100, value 78/100. Its strongest factor is value.
A0126Z0 price history
Key figures
- Market cap
- $6.36B
- Revenue (TTM)
- $1.05B
- P/E
- 16.63
- EPS
- -7,578.00
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- ₩773,000.00
- 52-week low
- ₩297,500.00
- Avg volume (3M)
- —
- Shares outstanding
- 24.84M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ImmunityBio, Inc.NasdaqGS: IBRX | $6.99B | $6.57 | -1.94% |
| Immunovant, Inc.NasdaqGS: IMVT | $6.86B | $33.17 | -0.12% |
| Kodiak Sciences Inc.NasdaqGM: KOD | $6.57B | $100.73 | -9.41% |
| RemeGen Co., Ltd.SEHK: 9995 | $6.39B | HK$63.50 | -4.80% |
| Biocon LimitedNSEI: BIOCON | $6.31B | Rs364.05 | -1.86% |
| Arrowhead Pharmaceuticals, Inc.NasdaqGS: ARWR | $6.17B | $43.65 | +1.25% |
| Scholar Rock Holding CorporationNasdaqGS: SRRK | $6.15B | $50.37 | +4.94% |
| Mirum Pharmaceuticals, Inc.NasdaqGM: MIRM | $6.14B | $93.99 | +0.71% |